![conference banner](/images/conference-banner.jpeg)
Abstract
The pathogenesis of a number of chronic inflammatory processes can be attributed to prolonged neovascularization. This article reviews recent studies on the vasculature targeting strategies for the treatment of chronic inflammatory diseases. Targeting of the vasculature of inflamed organs could underlie a new pharmacological approach in the treatment of inflammatory diseases by taking advantage of formulations that deliver drugs to blood vessels specifically located at disease sites and to inflammatory cells.
Keywords: antiangiogenesis, chronic inflammatory diseases, vascular targeting
Current Drug Targets - Inflammation & Allergy
Title: Development of Vasculature Targeting Strategies for the Treatment of Chronic Inflammatory Diseases
Volume: 4 Issue: 1
Author(s): Girolamo Ranieri, Roberto Ria, Aldo M. Roccaro, Angelo Vacca and Domenico Ribatti
Affiliation:
Keywords: antiangiogenesis, chronic inflammatory diseases, vascular targeting
Abstract: The pathogenesis of a number of chronic inflammatory processes can be attributed to prolonged neovascularization. This article reviews recent studies on the vasculature targeting strategies for the treatment of chronic inflammatory diseases. Targeting of the vasculature of inflamed organs could underlie a new pharmacological approach in the treatment of inflammatory diseases by taking advantage of formulations that deliver drugs to blood vessels specifically located at disease sites and to inflammatory cells.
Export Options
About this article
Cite this article as:
Ranieri Girolamo, Ria Roberto, Roccaro M. Aldo, Vacca Angelo and Ribatti Domenico, Development of Vasculature Targeting Strategies for the Treatment of Chronic Inflammatory Diseases, Current Drug Targets - Inflammation & Allergy 2005; 4 (1) . https://dx.doi.org/10.2174/1568010053622966
DOI https://dx.doi.org/10.2174/1568010053622966 |
Print ISSN 1568-010X |
Publisher Name Bentham Science Publisher |
Online ISSN 1568-010X |
Related Articles
-
Reversing Aberrant Methylation Patterns in Cancer
Current Medicinal Chemistry Liposomal Formulation of Monovalent Cholesteryl Cytofectins with Acyclic Head Groups and Gene Delivery: A Systematic Review
Current Pharmaceutical Biotechnology STING Activation and its Application in Immuno-Oncology
Current Topics in Medicinal Chemistry A Combination of Two Antioxidants (An SOD Mimic and Ascorbate) Produces a Pro-Oxidative Effect Forcing Escherichia coli to Adapt Via Induction of oxyR Regulon
Anti-Cancer Agents in Medicinal Chemistry Astrocytes: Adhesion Molecules and Immunomodulation
Current Drug Targets Arginine Deprivation, Autophagy, Apoptosis (AAA) for the Treatment of Melanoma
Current Molecular Medicine Cancer Stemness as a Target for Immunotherapy is Shaped by Proinflammatory Stress
Current Stem Cell Research & Therapy Multifaceted Role of Neuropilins in Cancer
Current Medicinal Chemistry HLA-G Expression in Cancers: Potential Role in Diagnosis, Prognosis and Therapy
Endocrine, Metabolic & Immune Disorders - Drug Targets Statins and Cancer
Anti-Cancer Agents in Medicinal Chemistry Impaired Expression and Function of Cancer-Related Enzymes by Anthocyans: An Update
Current Enzyme Inhibition subject Index To Volume 1
Current Molecular Medicine The Chlorophyll Catabolite Pheophorbide a as a Photosensitizer for the Photodynamic Therapy
Current Medicinal Chemistry Development of NGR-Based Anti-Cancer Agents for Targeted Therapeutics and Imaging
Anti-Cancer Agents in Medicinal Chemistry Intraperitoneal Oncolytic and Tumor Vaccination Therapy with Replication-Competent Recombinant Virus: The Herpes Paradigm
Current Gene Therapy Selectively Replicating Adenoviruses for Oncolytic Therapy
Current Cancer Drug Targets Exploring Mechanisms of MicroRNA Downregulation in Cancer
MicroRNA The Role of Mesothelin in Tumor Progression and Targeted Therapy
Anti-Cancer Agents in Medicinal Chemistry Diversity of Anticancer and Antimicrobial Compounds from Lichens and Lichen-derived Fungi: A Systematic Review (1985-2017)
Current Organic Chemistry Molecular Targeted Approaches for Treatment of Pancreatic Cancer
Current Pharmaceutical Design